Veterinary Vaccines Market
Market Insights on Veterinary Vaccines covering sales outlook, demand forecast & up-to-date key trends
Veterinary Vaccines Market by Product Type, Disease, Distribution Channel, Species & Region - Forecast 2022 - 2026
Veterinary Vaccines Market Outlook (2022-2026)
[193 Pages Report] Registering a year-on-year (YoY) growth rate of 6.5%, the global veterinary vaccines market size was valued at around US$ 10 Bn in 2021. However, with rapid rise in the veterinary vaccines sales amid increasing prevalence of animal diseases, the overall market is forecast to grow at a healthy CAGR of 7.2% between 2022 and 2026, surpassing a valuation of around US$ 14.1 Bn by 2026.
As the threat of another pandemic looms over the world, improving animal health has become a priority for people and governments worldwide. Annually, billions of dollars are being spent on pharmaceuticals and vaccines to protect animals from a wide range of diseases as well as to improve their immunity. This will continue to generate growth prospects for veterinary vaccines suppliers and manufacturers during the forecast period.
Similarly, rise in pet ownerships across developed and developing regions such as the U.K., China, the U.S., and India is expected to generate demand for pet vaccines during the forecast period, thereby fostering the growth of veterinary vaccines market.
|
Veterinary Vaccines Market Size (2022) |
US$ 10.7 Bn |
|
Veterinary Vaccines Sales Forecast (2026) |
US$ 14.1 Bn |
|
Veterinary Vaccines Market Forecast Growth Rate (2022 to 2026) |
7.2% CAGR |
|
Share of Top 5 Veterinary Vaccine Manufacturers |
55% |
Veterinary vaccines have become ideal preventive healthcare solutions for protecting animals from developing and contracting lethal diseases as well as for improving their immunity systems. They allow pet owners and farmers to curb the spread of infectious diseases, improve their pet’s health and minimize the healthcare costs.
Rapid growth in the animal healthcare market and companion animal vaccines market is expected to generate lucrative prospects for the manufacturers of veterinary vaccines during the forecast period between 2022 and 2026.
Sales of veterinary vaccines accounted for around 91.3% share of the global veterinary biologics market in 2021.
Based on product, attenuated live vaccines segment leads the veterinary vaccines market with nearly ¼ market share.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
6.78% |
|
H1, 2022 Projected |
6.85% |
|
H1, 2022 Outlook |
6.65% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 20 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 13 ↓ |
The variation between the BPS values observed within the global veterinary vaccines market in H1, 2022 - outlook over H1, 2022 projected period reflects a decline of 20 BPS units. Furthermore, a decline in BPS growth in H1-2022 over H1-2021 by 13 Basis Point Share (BPS) is demonstrated by the market.
The decline in the BPS values observed was attributed to the challenges associated with the cost, practicality, and challenges faced in licensing the product. Moreover, selection of appropriate therapeutic combinations is time consuming and pertains to an extensive amount of research activities.
Conversely, growing efforts to develop vaccines for zoonotic diseases which are prevalent in humans as well, is set to enhance the growth of the overall veterinary vaccines market.
Key developments in the market include the technological advances in animal immunization development, such as DNA vaccination. The market is highly influenced by regulations and licensing of biologics, under the impact of macro and industry factors.
Veterinary Vaccine Demand Analysis (2014-2021) Compared to Market Forecasts (2022-2026)
“Increasing Penetration of Animal Immunization Driving Market Expansion”
The global veterinary vaccines market is forecast to grow a robust CAGR of 7.2% between 2022 and 2026 in comparison to 6.5% registered from 2014 to 2021. Rising prevalence of zoonotic diseases, increasing demand for animal products, growing trend of pet adoption across the world, and exponential growth of animal healthcare products market are some of the key factors driving the global veterinary vaccines market.
Similarly, rapid expansion of veterinary respiratory disease treatment market and veterinary pain management drugs market due to increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.
Veterinary vaccines are gaining popularity for their ability to protect animal health as well as public health as they effectively mimic the naturally acquired immunity. Veterinary vaccines sales are especially high across developed nations due to increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.
In recent years, spending on animals has increased substantially on account of rising pet adoption rates and growing awareness about maintaining proper health of animals. Pet owners are spending large amounts on immunizing their pets. This will continue to push the demand for pet vaccines during the forecast period and will eventually expand the global veterinary vaccines market size.
Similarly, introduction of technologically advanced vaccinations, increasing livestock population, rising government investments and initiatives to tackle the burden of animal diseases, and expanding pet care market across developing regions are expected to create growth avenues within the global veterinary vaccines market during the forthcoming years.
Which Factors are Shaping Veterinary Vaccines Market Growth?
“Growing Importance of Developing Protozoan Parasitic Vaccines”
The prevalence of a variety of animal diseases worldwide not only affects animals' health but is also dangerous for humans. For this reason, various governments are adopting mass vaccination programs for animals to stop disease transmission from animals to humans. This is expected to create significant demand for vaccines for national stockpiles.
Increasing initiatives and investments by governments around the world to tackle animal diseases burden and ensure food security is anticipated to push the demand for veterinary vaccines in future.
Currently, veterinary healthcare industry is experiencing immense demand for protozoan parasitic vaccines and the trend is likely to escalate during the forecast period. Leading players have shifted their preference towards the production of third-generation DNA veterinary vaccines for protection against protozoan parasites due to their effective nature.
Consequently, booming animal vaccines market worldwide will continue to create a conducive environment for veterinary vaccine suppliers during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Restraining Factors are Impeding Growth in the Market?
“Lack of Animal Vaccination Awareness Among Smallholder Farmers”
Despite its optimistic stance, the global veterinary vaccines market is facing various challenges that are likely to slow down its growth during the forecast period. Some of these factors are the lack of awareness and accessibility for smaller farmers, low healthcare awareness in some regions, and the possibility of harmful outcomes of animal vaccinations. Similarly, high storage and transportation cost of animal vaccinations is also limiting market expansion.
What Makes North America an Attractive Market for Veterinary Vaccines?
“Huge Demand for Pet Vaccines Across the Continent”
North America continues to shape revenue generation in the global veterinary vaccines market due to uptick in usage of efficacious pet vaccines in tandem with tech-advanced vaccine delivery equipment, rise in pet adoption rates, and rapid expansion of animal vaccines market.
Furthermore, increasing awareness among consumers regarding the prevailing veterinary vaccine market trends is likely to favor market in North America during the forecast period.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Analysis
What is the Demand Outlook for Veterinary Vaccines in the U.S.?
“Advancements in Biotechnology and Veterinary Science to Drive Market Expansion”
The U.S. will continue to be a prominent market for veterinary vaccines due to increasing frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, emergence of new veterinary vaccine market trends.
Similarly, increasing focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology and rapid growth of animal healthcare market is expected to create a favorable platform for the development of veterinary vaccines in the U.S.
How is the Market for Veterinary Vaccines Faring in China?
“Growing Innovation of Veterinary Medical Devices To Fuel Growth”
China is also emerging as an opportunistic market for veterinary vaccines, underpinned by collaborative initiatives of governments and private firms to promote better animal healthcare with advanced veterinary medical devices.
Livestock and companion animal owners across the country are showing a keen interest in following regular vaccination schedules, which is expected to push the veterinary vaccines sales in the country during the forecast period.
Category-wise Insights
Why is the Demand for Attenuated Live Vaccines Increasing?
“Attenuated Live Vaccines Improving Public Health by Controlling Contagious Diseases”
Attenuated live vaccines remain the most preferred product in the global veterinary vaccines market and are expected to account for 24.3% of the global market share in 2022. These vaccines are high in demand due to their strong, effective and long-lasting nature.
Which Species Type Will Emerge as a Key Market Contributor?
“Increasing Livestock Animal Immunization Creating Strong Demand for Veterinary Vaccines”
In terms of species, livestock animals accounted for a major revenue share in the market due to growing need for livestock animal immunization to assure the safety of food and dairy products.
Livestock animals are essential sources for primary and secondary food items that humans utilize in their daily routine life. Thus, ensuring proper health of these has become a top priority, thereby prompting farmers to use healthcare products like veterinary vaccines.
Similarly, rapid growth of animal vaccines market across developed and developing regions will further aid the growth in this segment.
However, rapid adoption of pets and growing popularity
Competitive Landscape
Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health, Merck & Co., Inc. and Bayer AG are some of the key players profiled in the global veterinary vaccines market report.
Leading veterinary vaccine manufacturers are continuously investing in research and development activities for introducing effective vaccines. Besides this, they gave adopting various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint. For instance,
- In January 2020, Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, and Automazioni VX Inc. introduced a newly designed subcutaneous chick vaccination technology called Innoject Pro.
- In September 2020, Ceva Santé Animale increased its production capacity by three-fold for bacterial autogenous vaccines (primarily, for pigs and poultry) at its French plant.
Scope Of Report
FMI’s latest report presents an in-depth analysis of veterinary vaccines market by breaking its down into various segments and sub-segments. This makes the study easy and more interesting, which in turn significantly enriches consumer experience.
The report explains how rising concerns related to disease transmission in animals can bring veterinary vaccines market into the limelight. Besides this, it answers queries like why is the demand for veterinary vaccines rising across North America? How will rise in pet adoption affect market growth? and what makes Asia Pacific a promising market for manufacturers?
FMI also provides valuable insights into consumer demand and explains in detail about innovations and growth strategies adopted by key participants to increase sales. Apart from examining the impact of increasing health awareness, the report highlights the interrelationship between veterinary vaccines market to explore hidden opportunities.
Uncover the key factors behind exponential growth of veterinary vaccines market with Future Market Insights latest industry analysis.
The Veterinary Vaccines market analysis includes:
- A 4-year realistic veterinary vaccine sales forecast slicing across multiple verticals
- Comprehensive information on demand and sales prospects across 25 countries
- Detailed analysis of key market dynamics including drivers, restraints, and emerging trends
- Key insights into leading market segments along with their respective shares.
- Graphical representation of demand and sales trends for veterinary vaccines
- Top players in the market and their collective share
- Key strategies adopted by leading producers of animal vaccines to improve sales
- Growth potential of veterinary vaccines market in developing economies
- Influence of rising pet ownership on veterinary vaccine sales
- Role of government in the expansion of veterinary vaccines market size
|
Attribute |
Details |
|
Forecast Period |
2022-2026 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
US$ Million for Value and MT for Volume |
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Key Segments Covered |
|
|
Key regions covered |
North America
Latin America
Western Europe
Eastern Europe
South Asia Pacific
Middle East & Africa GCC Countries
Rest of the World
|
|
By Species |
|
|
Key Companies Covered |
Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health, Merck & Co., Inc., Bayer AG, Virbac Group, Ceva Santé Animale, Phibro Animal Health Corporation and others. |
|
Customization & Pricing |
Available upon Request |
Key Segments of Veterinary Vaccines Industry Survey
By Product:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Disease:
- Anaplasmosis
- Canine Parvovirus
- Foot & Mouth Disease
- New Castle Disease
- Distemper Disease
- Influenza
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Species:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock Animals
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Region:
- North America Veterinary Vaccines Market
- Latin America Veterinary Vaccines Market
- Europe Veterinary Vaccines Market
- East Asia Veterinary Vaccines Market
- South Asia & Pacific Veterinary Vaccines Market
- Middle East & Africa (MEA) Veterinary Vaccines Market
Frequently Asked Questions
The global veterinary vaccines market reached around US$ 10 Bn in 2021.
Increased awareness among farmers, rising transmission of zoonotic diseases, surging animal ownership, and new product launches will drive adoption of veterinary vaccines.
Accounting for 24.3% share, attenuated live vaccines segment leads the veterinary vaccines market.
Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health, Merck & Co., Inc., and Bayer AG are prominent veterinary vaccine manufacturers.
The global veterinary vaccines market is projected to register a CAGR of 7.2% during 2022-2026.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Market Context
4.1. Regulatory Scenario
4.2. Reimbursement Scenario
5. Market Background
5.1. Macro-Economic Factors
5.2. Forecast Factors - Relevance & Impact
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Veterinary Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2026
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2026
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026, by Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product, 2014-2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022 - 2026
7.3.1. Attenuated Live Vaccines
7.3.2. Conjugate Vaccines
7.3.3. Inactivated Vaccines
7.3.4. Subunit Vaccines
7.3.5. Toxoid Vaccines
7.3.6. DNA Vaccines
7.3.7. Recombinant Vaccines
8. Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026, by Disease
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Disease, 2014-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Disease, 2022 – 2026
8.3.1. Anaplasmosis
8.3.2. Canine Parvovirus
8.3.3. Foot & Mouth Disease
8.3.4. New Castle Disease
8.3.5. Distemper Disease
8.3.6. Influenza
8.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)
8.3.8. Others
9. Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2026
9.3.1. Veterinary Clinics
9.3.2. Veterinary Hospitals
9.3.3. Veterinary Research Institutes
9.3.4. Retail Pharmacies
10. Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026, by Species
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Species, 2014-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Species, 2022 – 2026
10.3.1. Companion Animals
10.3.1.1. Canine
10.3.1.2. Avian
10.3.1.3. Feline
10.3.2. Livestock Animals
10.3.2.1. Aquatic
10.3.2.2. Bovine
10.3.2.3. Porcine
10.3.2.4. Ovine/Caprine
10.3.2.5. Poultry
10.3.3. Equine
11. Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2026
11.3.1. North America
11.3.2. Latin America
11.3.3. Western Europe
11.3.4. Eastern Europe
11.3.5. APEJ
11.3.6. Japan
11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis By Region
12. North America Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
12.3.1. By Product
12.3.2. By Disease
12.3.3. By Distribution Channel
12.3.4. By Species
12.3.5. By Country
12.3.5.1. U.S.
12.3.5.2. Canada
12.4. Market Attractiveness Analysis
12.4.1. By Product
12.4.2. By Disease
12.4.3. By Distribution Channel
12.4.4. By Species
12.4.5. By Country
13. Latin America Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
13.3.1. By Product
13.3.2. By Disease
13.3.3. By Distribution Channel
13.3.4. By Species
13.3.5. By Country
13.3.5.1. Brazil
13.3.5.2. Mexico
13.3.5.3. Argentina
13.3.5.4. Rest of Latin America
13.4. Market Attractiveness Analysis
13.4.1. By Product
13.4.2. By Disease
13.4.3. By Distribution Channel
13.4.4. By Species
13.4.5. By Country
14. Western Europe Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
14.3.1. By Product
14.3.2. By Disease
14.3.3. By Distribution Channel
14.3.4. By Species
14.3.5. By Country
14.3.5.1. Germany
14.3.5.2. Italy
14.3.5.3. France
14.3.5.4. U.K.
14.3.5.5. Spain
14.3.5.6. BENEXULAX
14.3.5.7. Nordic Countries
14.3.5.8. Rest of Western Europe
14.4. Market Attractiveness Analysis
14.4.1. By Product
14.4.2. By Disease
14.4.3. By Distribution Channel
14.4.4. By Species
14.4.5. By Country
15. Eastern Europe Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
15.3.1. By Product
15.3.2. By Diseases
15.3.3. By Distribution Channel
15.3.4. By Species
15.3.5. By Country
15.3.5.1. Russia
15.3.5.2. Poland
15.3.5.3. Rest of Eastern Europe
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Disease
15.4.3. By Distribution Channel
15.4.4. By Species
15.4.5. By Country
16. APEJ Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
16.3.1. By Product
16.3.2. By Disease
16.3.3. By Distribution Channel
16.3.4. By Species
16.3.5. By Country
16.3.5.1. India
16.3.5.2. China
16.3.5.3. ASEAN
16.3.5.4. Australia & New Zealand
16.3.5.5. Rest of APEJ
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Disease
16.4.3. By Distribution Channel
16.4.4. By Species
16.4.5. By Country
17. Japan Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
17.3.1. By Product
17.3.2. By Disease
17.3.3. By Distribution Channel
17.3.4. By Species
17.4. Market Attractiveness Analysis
17.4.1. By Product
17.4.2. By Disease
17.4.3. By Distribution Channel
17.4.4. By Species
18. Middle East and Africa Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2026
18.3.1. By Product
18.3.2. By Disease
18.3.3. By Distribution Channel
18.3.4. By Species
18.3.5. By Country
18.3.5.1. GCC Countries
18.3.5.2. South Africa
18.3.5.3. Rest of Middle East and Africa
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Disease
18.4.3. By Distribution Channel
18.4.4. By Species
18.4.5. By Country
19. Market Structure Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Boehringer Ingelheim GmbH
20.2.2. Zoetis Inc.
20.2.3. Elanco Animal Health
20.2.4. Merck & Co., Inc.
20.2.5. Bayer AG
20.2.6. Ceva Santé Animale
20.2.7. Virbac Group
20.2.8. Indian Immunologicals Limited
20.2.9. Phibro Animal Health Corporation
20.2.10. Hester Biosciences Limited
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 02: Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 03: Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 04: Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 05: Global Veterinary Vaccines Market Analysis 2014-2021 and Forecast 2022-2026, By Region
Table 06: North America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Country
Table 07: North America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 08: North America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 09: North America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 10: North America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 11: Latin America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Country
Table 12: Latin America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 13: Latin America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 14: Latin America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 15: Latin America Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 16: Western Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Country
Table 17: Western Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 18: Western Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 19: Western Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 20: Western Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 21: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Country
Table 22: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 23: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 24: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 25: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 26: APEJ Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Country
Table 27: APEJ Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 28: APEJ Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 29: APEJ Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 30: APEJ Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 31: Japan Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 32: Japan Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 33: Japan Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 34: Japan Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Table 35: Middle East & Africa Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Country
Table 36: Middle East & Africa Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Product
Table 37: Middle East & Africa Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Diseases
Table 38: Middle East & Africa Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Distribution Channel
Table 39: Middle East & Africa Veterinary Vaccines Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2026 , By Species
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Veterinary Vaccines Market Share Analysis (%), By Product, 2021A
Figure 02: Global Veterinary Vaccines Market Share Analysis (%), By Diseases, 2021A
Figure 03: Global Veterinary Vaccines Market Share Analysis (%), By Distribution Channels, 2021A
Figure 04: Global Veterinary Vaccines Market Share Analysis (%), By Species, 2021A
Figure 05: Global Veterinary Vaccines Market Share Analysis (%), By Region, 2021A
Figure 06: Global Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 07: Global Veterinary Vaccines Market Forecast & Y-o-Y Growth, 2022-2026
Figure 08: Global Veterinary Vaccines Market Absolute $ Opportunity (US$ Mn) Analysis, 2021-2026
Figure 09: Global Veterinary Vaccines Market Y-o-Y Growth (%) Analysis, 2021-2026
Figure 10: Global Veterinary Vaccines Market Value Share (%) Analysis 2022 & 2030, By Product
Figure 11: Global Veterinary Vaccines Market Y-o-Y Growth (%) Analysis 2021-2030, By Product
Figure 12: Global Veterinary Vaccines Market Attractiveness Analysis 2022-2026, By Product
Figure 13: Global Veterinary Vaccines Market Value Share (%) Analysis 2022 & 2030, By Diseases
Figure 14: Global Veterinary Vaccines Market Y-o-Y Growth (%) Analysis 2021-2030, By Diseases
Figure 15: Global Veterinary Vaccines Market Attractiveness Analysis 2022-2026, By Diseases
Figure 16: Global Veterinary Vaccines Market Value Share (%) Analysis 2022 & 2030, By Distribution Channel
Figure 17: Global Veterinary Vaccines Market Y-o-Y Growth (%) Analysis 2021-2030, By Distribution Channel
Figure 18: Global Veterinary Vaccines Market Attractiveness Analysis 2022-2026, By Distribution Channel
Figure 19: Global Veterinary Vaccines Market Value Share (%) Analysis 2022 & 2030, By Species
Figure 20: Global Veterinary Vaccines Market Y-o-Y Growth (%) Analysis 2021-2030, By Species
Figure 21: Global Veterinary Vaccines Market Attractiveness Analysis 2022-2026, By Species
Figure 22: Global Veterinary Vaccines Market Value Share (%) Analysis 2022 & 2030, By Region
Figure 23: Global Veterinary Vaccines Market Y-o-Y Growth (%) Analysis 2021-2030, By Region
Figure 24: Global Veterinary Vaccines Market Attractiveness Analysis 2022-2026, By Region
Figure 25: North America Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 26: North America Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 27: North America Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 28: North America Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 29: North America Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 30: North America Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 31: North America Veterinary Vaccines Market Attractiveness Analysis, By Country
Figure 32: Latin America Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 33: Latin America Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 34: Latin America Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 35: Latin America Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 36: Latin America Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 37: Latin America Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 38: Latin America Veterinary Vaccines Market Attractiveness Analysis, By Country
Figure 39: Western Europe Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 40: Western Europe Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 41: Western Europe Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 42: Western Europe Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 43: Western Europe Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 44: Western Europe Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 45: Western Europe Veterinary Vaccines Market Attractiveness Analysis, By Country
Figure 46: Eastern Europe Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 47: Eastern Europe Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 48: Eastern Europe Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 49: Eastern Europe Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 50: Eastern Europe Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 51: Eastern Europe Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 52: Eastern Europe Veterinary Vaccines Market Attractiveness Analysis, By Country
Figure 53: APEJ Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 54: APEJ Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 55: APEJ Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 56: APEJ Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 57: APEJ Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 58: APEJ Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 59: APEJ Veterinary Vaccines Market Attractiveness Analysis, By Country
Figure 60: Japan Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 61: Japan Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 62: Japan Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 63: Japan Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 64: Japan Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 65: Japan Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 66: Middle East & Africa Veterinary Vaccines Market Value Analysis, 2014-2021
Figure 67: Middle East & Africa Veterinary Vaccines Market Forecast & Y-o-Y growth, 2022-2026
Figure 68: Middle East & Africa Veterinary Vaccines Market Attractiveness Analysis, By Product
Figure 69: Middle East & Africa Veterinary Vaccines Market Attractiveness Analysis, By Disease
Figure 70: Middle East & Africa Veterinary Vaccines Market Attractiveness Analysis, By Distribution Channel
Figure 71: Middle East & Africa Veterinary Vaccines Market Attractiveness Analysis, By Species
Figure 72: Middle East & Africa Veterinary Vaccines Market Attractiveness Analysis, By Country
Figure 73: Global Veterinary Vaccines Market Share (%) Analysis
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
